Literature DB >> 25287744

Neutral sphingomyelinase-2 is a redox sensitive enzyme: role of catalytic cysteine residues in regulation of enzymatic activity through changes in oligomeric state.

P Patrick Dotson1, Alexander A Karakashian1, Mariana N Nikolova-Karakashian1.   

Abstract

Neutral sphingomyelinase-2 (nSMase-2) is the major sphingomyelinase activated in response to pro-inflammatory cytokines and during oxidative stress. It is a membrane-bound 655 amino acid protein containing 22 cysteine residues. In this study, we expressed recombinant mouse nSMase-2 protein in Escherichia coli, and investigated whether nSMase-2 is a redox sensitive enzyme. Our results demonstrate that nSMase-2 exists as both monomers and multimers that are associated with high and low enzymatic activity respectively. Mutational analysis of nSMase-2 identified within its C-terminal catalytic domain several oxidant-sensitive cysteine residues that were shown to be involved in enzyme oligomerization. Changing Cys(617) to Ser for example is a gain-of-function mutation associated with a decreased propensity for oligomerization. Alternatively, nSMase-2 expression in a bacterial strain that lacks endogenous thioredoxin, Rosetta-gami2, results in increased oligomer formation and lower enzyme activity. Phenotypic rescue was accomplished by treating nSMase-2 lysates with recombinant human thioredoxin. This indicates that nSMase-2 may be a novel substrate for thioredoxin. FRET analysis confirmed the presence of nSMase-2 multimers in mammalian HEK cells and their localization to the plasma membrane. In conclusion, our results identify nSMase-2 as a redox-sensitive enzyme, whose basal activity is influenced by thioredoxin-mediated changes in its oligomeric state.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25287744      PMCID: PMC4526461          DOI: 10.1042/BJ20140665

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Irreversible inactivation of magnesium-dependent neutral sphingomyelinase 1 (NSM1) by peroxynitrite, a nitric oxide-derived oxidant.

Authors:  Michelle Josephs; Matilda Katan; Fernando Rodrigues-Lima
Journal:  FEBS Lett       Date:  2002-11-06       Impact factor: 4.124

Review 2.  Sulfenic acid in human serum albumin.

Authors:  S Carballal; B Alvarez; L Turell; H Botti; B A Freeman; R Radi
Journal:  Amino Acids       Date:  2006-10-24       Impact factor: 3.520

3.  Ceramide-mediated apoptosis in lung epithelial cells is regulated by glutathione.

Authors:  S N Lavrentiadou; C Chan; T Kawcak; T Ravid; A Tsaba; A van der Vliet; R Rasooly; T Goldkorn
Journal:  Am J Respir Cell Mol Biol       Date:  2001-12       Impact factor: 6.914

4.  Induction of thioredoxin by ultraviolet-A radiation prevents oxidative-mediated cell death in human skin fibroblasts.

Authors:  C Didier; I Kerblat; C Drouet; A Favier; J C Béani; M J Richard
Journal:  Free Radic Biol Med       Date:  2001-09-01       Impact factor: 7.376

5.  Neutral sphingomyelinase activation in endothelial and glial cell death induced by amyloid beta-peptide.

Authors:  Ding-I Yang; Chen-Hsiung Yeh; Shawei Chen; Jan Xu; Chung Y Hsu
Journal:  Neurobiol Dis       Date:  2004-10       Impact factor: 5.996

6.  Expression of neutral sphingomyelinase-2 (NSMase-2) in primary rat hepatocytes modulates IL-beta-induced JNK activation.

Authors:  Alexander A Karakashian; Natalia V Giltiay; George M Smith; Mariana N Nikolova-Karakashian
Journal:  FASEB J       Date:  2004-04-01       Impact factor: 5.191

7.  Aging in rat causes hepatic hyperresposiveness to interleukin-1beta which is mediated by neutral sphingomyelinase-2.

Authors:  Kristina Rutkute; Alexander A Karakashian; Natalia V Giltiay; Aneta Dobierzewska; Mariana N Nikolova-Karakashian
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

8.  Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism.

Authors:  Norma Marchesini; Chiara Luberto; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2003-02-03       Impact factor: 5.157

9.  Activation of human acid sphingomyelinase through modification or deletion of C-terminal cysteine.

Authors:  Huawei Qiu; Tim Edmunds; Jennifer Baker-Malcolm; Kenneth P Karey; Scott Estes; Cordula Schwarz; Heather Hughes; Scott M Van Patten
Journal:  J Biol Chem       Date:  2003-06-11       Impact factor: 5.157

10.  Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway.

Authors:  Jiunn-Tay Lee; Jan Xu; Jin-Moo Lee; Grace Ku; Xianlin Han; Ding-I Yang; Shawei Chen; Chung Y Hsu
Journal:  J Cell Biol       Date:  2004-01-05       Impact factor: 10.539

View more
  6 in total

1.  Dietary inulin decreases circulating ceramides by suppressing neutral sphingomyelinase expression and activity in mice.

Authors:  Pan Deng; Jessie B Hoffman; Michael C Petriello; Chun-Yan Wang; Xu-Sheng Li; Maria P Kraemer; Andrew J Morris; Bernhard Hennig
Journal:  J Lipid Res       Date:  2019-10-11       Impact factor: 5.922

Review 2.  Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise.

Authors:  Fei Yin
Journal:  FEBS J       Date:  2022-01-07       Impact factor: 5.622

3.  Hyaluronan synthase-2 upregulation protects smpd3-deficient fibroblasts against cell death induced by nutrient deprivation, but not against apoptosis evoked by oxidized LDL.

Authors:  Sandra Garoby-Salom; Myriam Rouahi; Elodie Mucher; Nathalie Auge; Robert Salvayre; Anne Negre-Salvayre
Journal:  Redox Biol       Date:  2014-12-16       Impact factor: 11.799

Review 4.  Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation.

Authors:  Maja Jazvinšćak Jembrek; Patrick R Hof; Goran Šimić
Journal:  Oxid Med Cell Longev       Date:  2015-05-24       Impact factor: 6.543

5.  Stress induces major depressive disorder by a neutral sphingomyelinase 2-mediated accumulation of ceramide-enriched exosomes in the blood plasma.

Authors:  Fabian Schumacher; Alexander Carpinteiro; Michael J Edwards; Gregory C Wilson; Simone Keitsch; Matthias Soddemann; Barbara Wilker; Burkhard Kleuser; Katrin Anne Becker; Christian P Müller; Johannes Kornhuber; Erich Gulbins
Journal:  J Mol Med (Berl)       Date:  2022-08-31       Impact factor: 5.606

Review 6.  Neutral sphingomyelinase-2 and cardiometabolic diseases.

Authors:  Sardar Sindhu; Yat Hei Leung; Hossein Arefanian; S R Murthy Madiraju; Fahd Al-Mulla; Rasheed Ahmad; Marc Prentki
Journal:  Obes Rev       Date:  2021-03-18       Impact factor: 9.213

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.